Tag: novo nordisk

February 9, 2018

Novo Nordisk Ozempic approved in the EU for the treatment of type 2 diabetes

Novo Nordisk (CPH:NOVO-B) announced that the European Commission (EC) has granted marketing authorisation for Ozempic® (semaglutide) for the treatment of adults...
February 8, 2018

Everthing You Need to Know About the Longevity Thematic ETF

In the last year, LNGR has given investors a 23.67 percent return, and is expected to increase by 29.38 percent...
December 20, 2017

Pharma Trends 2017: FDA Pushes Creation of More Generic Drugs

INN takes a look at some of the major stories and developments in the pharma industry during 2017.
December 5, 2016

Novo Nordisk Files for Regulatory Approval of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes

Novo Nordisk today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for semaglutide,...
November 28, 2016

Novo Nordisk A/S – Share Repurchase Programme

On 28 October 2016, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014...
September 29, 2016

Novo Nordisk to Reduce Workforce by Approximately 1,000 Employees

Novo Nordisk has today announced its intention to reduce its workforce by approximately 1,000 employees of the 42,300 positions in...
September 26, 2016

Sobi Appoints Milan Zdravkovic Senior Vice President, Head of Research &Development

Swedish Orphan Biovitrum today announced that Milan Zdravkovic has been appointed Senior Vice President, Head of Research & Development.
September 19, 2016

FenoLogica Biosciences Signs Licensing and Collaboration Agreement With the Pacific Northwest Research Institute

FenoLogica Biosciences Inc., a Seattle-WA-based life sciences company, announces completion of a licensing and collaboration agreement with the Pacific Northwest...
August 25, 2016

European Diabetes Device Market Growing Due to Technological Advancements

According to iData Research’s report entitled, “European Market Report Suite for Diabetes Diagnosis, Treatment and Drug Delivery“, market growth is...
June 22, 2016

The Brexit and Biotech: What You Need to Know

How is the Brexit referendum affecting the UK's biotech and life sciences sectors?